Presentation ESC 2016 “Off Hours” Versus “On Hours” Presentation in ST-Segment Elevation Myocardial Infarction: Findings from CHAMPION PHOENIX Presenter: Deepak L. Bhatt August 31, 2016
Presentation TCT 2015 TCT 79: Efficacy of Cangrelor in Lesions With High-Risk and Low-Risk Angiographic Characteristics The CHAMPION PHOENIX Trial Presenter: Lisa K. Jennings, Neal S. Kleiman, Gregg W. Stone October 13, 2015
Presentation TCT 2015 TCT 75: Cangrelor Improves Ischemic Outcomes in Patients With Multivessel Disease and Single Vessel Disease Undergoing PCI Insights From the CHAMPION PHOENIX Trial Presenter: Lisa K. Jennings, Neal S. Kleiman, Freddy Abnousi October 13, 2015
Presentation CHAMPION PHOENIX: Effect of Cangrelor and Access Site on Ischemic and Bleeding Events Presenter: JA. Gutierrez October 05, 2015
Presentation TCT 2014 TCT 482: Effect of Cangrelor on Ischemic Endpoints: Further Analyses From CHAMPION PHOENIX Presenter: John M. Lasala, Stuart J. Pocock, Deepak L. Bhatt September 16, 2014
Presentation TCT 2014 Effect of Cangrelor on Ischemic Endpoints: Further Analyses from CHAMPION PHOENIX Presenter: Deepak Bhatt September 16, 2014
Presentation TCT 2014 YES: CHAMPION PHOENIX was Convincing! Presenter: Deepak L. Bhatt September 14, 2014
Presentation ACC 2014 Incidence and Impact of Stent Thrombosis During Percutaneous Coronary Intervention: Comparison of Cangrelor and Clopidogrel from the CHAMPION PHOENIX Trial Presenter: Philippe Généreux March 30, 2014
Presentation TCT 2013 Pro Position: The Data - Phoenix and Meta-Analysis of the Champion Clinical Trial Program! Presenter: Philippe Gabriel Steg October 31, 2013
Presentation TCT 2013 CHAMPION PHOENIX and CHAMPION Program Meta-Analysis Presenter: Philippe Gabriel Steg October 31, 2013
Presentation TCT 2013 CHAMPION PHOENIX IPST: Implications of Intraprocedural Stent Thrombosis During PCI from a Prospective, Randomized Trial of a Potent Intravenous ADP Antagonist vs. a Standard Ora... Presenter: Philippe Généreux October 28, 2013